Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-9929.03%
operating margin TTM
-10392.14%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -17.59 |
| peg ratio | 1.66 |
| price to book ratio | 19.78 |
| price to sales ratio | 1,757.29 |
| enterprise value multiple | -18.72 |
| price fair value | 19.78 |
profitability ratios | |
|---|---|
| gross profit margin | -91.08% |
| operating profit margin | -10392.14% |
| pretax profit margin | -9929.03% |
| net profit margin | -9929.03% |
| return on assets | -91.36% |
| return on equity | -86.67% |
| return on capital employed | -108.66% |
liquidity ratios | |
|---|---|
| current ratio | 7.26 |
| quick ratio | 7.24 |
| cash ratio | 6.97 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 52.40 |
| operating cycle | 128.70 |
| days of payables outstanding | 702.28 |
| cash conversion cycle | -573.57 |
| receivables turnover | 4.78 |
| payables turnover | 0.52 |
| inventory turnover | 6.97 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.09 |
| debt equity ratio | 0.11 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.10 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -7.56 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.80 |
| cash per share | 1.01 |
| operating cash flow per share | -0.80 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -7.56 |
| short term coverage ratios | -33.26 |
| capital expenditure coverage ratio | -171.82 |
Frequently Asked Questions
When was the last time Pulse Biosciences, Inc. (NASDAQ:PLSE) reported earnings?
Pulse Biosciences, Inc. (PLSE) published its most recent earnings results on 04-05-2026.
What is Pulse Biosciences, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Pulse Biosciences, Inc. (NASDAQ:PLSE)'s trailing twelve months ROE is -86.67%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Pulse Biosciences, Inc. (PLSE) currently has a ROA of -91.36%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did PLSE's net profit margin stand at?
PLSE reported a profit margin of -9929.03% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is PLSE's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 7.26 in the most recent quarter. The quick ratio stood at 7.24, with a Debt/Eq ratio of 0.11.